International Expansion Stays On Nichi-Iko’s Agenda As Sagent Struggles

Japan’s Nichi-Iko is looking to grow its overseas sales by around a fifth each year, even as its North American injectables affiliate Sagent struggles to move forward and to make a profit.  

Network
Nichi-Iko intends to expand from its bases in Japan and North America in a bid to become a leading global generics player • Source: Shutterstock

More from Generics

More from Products